| http://www.w3.org/ns/prov#value | - Genes other than IL-2 which could be of therapeutic benefit include such other immunomodlators as TNF???, or interferon gamma, prodrug activating enzymes, enzyme inhibitors, tumour antigens (to provoke the hosts immune reactivity to the tumour) and anti-oncogenes (antibodies or antisense RNA).
|
